Madrigal Pharmaceuticals, Inc. MDGL
1,003 filings, 6 in the last 30 days
SEC filing indexWhat the 8-Ks said
1 event in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Dec 11, 2025 CEO, CFO, COO or CAOCAO change “(the “Company”) appointed Rita Thakkar as Senior Vice President and Chief Accounting Officer of the Company, effective January 12, 2026.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 74 events
- Nov 6, 2026 Buy BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX / BAKER JULIAN / 667, L.P. / Baker Brothers Life Sciences LP (Director) bought $35.0Mopen-market purchase on Nov 4, 2026
- Nov 6, 2026 Planned sale SHANNON KELLEY (Officer) gave notice of a planned sale of 1,077 shares worth about $431KForm 144, approximate sale date Nov 6, 2026, under a 10b5-1 plan adopted Jul 31, 2026
- Nov 3, 2026 Planned sale Carole Huntsman (Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 2,868 shares, runs to Jan 31, 2027
- Nov 3, 2026 Planned sale Shannon Kelley (Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 8,927 shares, runs to Sep 1, 2027
- Nov 3, 2026 Planned sale Mardi Dier (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 8,875 shares, runs to Jul 31, 2027
- Nov 3, 2026 Planned sale Rebecca Taub, M.D. (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 62,000 shares, runs to Mar 1, 2028
- Nov 3, 2026 8-K Quarterly results8-K item 2.02
- Nov 3, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Sep 28, 2026 Planned sale PAUL FRIEDMAN (Director) gave notice of a planned sale of 50,000 shares worth about $25.8MForm 144, approximate sale date Sep 28, 2026, under a 10b5-1 plan adopted Aug 28, 2026
- Sep 11, 2026 Planned sale WILLIAM SIBOLD (Director, Officer) gave notice of a planned sale of 5,221 shares worth about $2.8MForm 144, approximate sale date Sep 11, 2026, under a 10b5-1 plan adopted Jun 5, 2026
- Sep 9, 2026 Planned sale William John Sibold (Officer and Director) gave notice of a planned sale of 6,362 shares worth about $3.4MForm 144, approximate sale date Sep 9, 2026
- Aug 20, 2026 Planned sale Shannon Kelley (Officer) gave notice of a planned sale of 664 shares worth about $337KForm 144, approximate sale date Aug 17, 2026
- Aug 12, 2026 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Jul 30, 2026 Planned sale William Sibold (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 6,706 shares, runs to Sep 30, 2027
- Jul 30, 2026 8-K Quarterly results8-K item 2.02
- Jul 30, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 20, 2026 Planned sale William Sibold (Officer and Director) gave notice of a planned sale of 2,500 shares worth about $1.4MForm 144, approximate sale date Jul 20, 2026
- Jun 17, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- Jun 1, 2026 Planned sale DAVID SOERGEL (Officer) gave notice of a planned sale of 1,042 shares worth about $518KForm 144, approximate sale date Jun 1, 2026, under a 10b5-1 plan adopted Mar 2, 2026
- May 22, 2026 Planned sale RICHARD LEVY (Director) gave notice of a planned sale of 5,682 shares worth about $2.9MForm 144, approximate sale date May 22, 2026, under a 10b5-1 plan adopted Feb 20, 2026
- May 18, 2026 Planned sale David Soergel (Officer) gave notice of a planned sale of 844 shares worth about $442KForm 144, approximate sale date May 18, 2026
- May 6, 2026 Planned sale Richard Levy, M.D. (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 5,682 shares, runs to Dec 31, 2026
- May 6, 2026 Planned sale David Soergel, M.D. (Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 4,293 shares, runs to Dec 31, 2026
- May 6, 2026 8-K Quarterly results8-K item 2.02
- May 6, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 28, 2026 8-K Director or officer change8-K item 5.02
- Mar 6, 2026 Planned sale MARDI DIER (Officer) gave notice of a planned sale of 1,336 shares worth about $587KForm 144, approximate sale date Mar 6, 2026, under a 10b5-1 plan adopted Sep 2, 2025
- Mar 6, 2026 Planned sale Rebecca Taub (Director) gave notice of a planned sale of 491 shares worth about $216KForm 144, approximate sale date Mar 6, 2026
- Mar 6, 2026 Planned sale Carole Huntsman (Officer) gave notice of a planned sale of 419 shares worth about $184KForm 144, approximate sale date Mar 6, 2026
- Mar 6, 2026 Planned sale Shannon Kelley (Officer) gave notice of a planned sale of 360 shares worth about $158KForm 144, approximate sale date Mar 6, 2026
- Mar 6, 2026 Planned sale William Sibold (Officer and Director) gave notice of a planned sale of 1,663 shares worth about $731KForm 144, approximate sale date Mar 6, 2026
- Mar 6, 2026 Planned sale Mardi Dier (Officer) gave notice of a planned sale of 646 shares worth about $284KForm 144, approximate sale date Mar 6, 2026
- Mar 2, 2026 Planned sale Mardi Dier (Officer) gave notice of a planned sale of 1,183 shares worth about $511KForm 144, approximate sale date Mar 2, 2026
- Feb 19, 2026 8-K Quarterly results8-K item 2.02
- Feb 19, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 30, 2026 8-K Material agreement signed8-K item 1.01
- Jan 26, 2026 Planned sale CAROLE A HUNTSMAN (Officer) gave notice of a planned sale of 570 shares worth about $274KForm 144, approximate sale date Jan 26, 2026, under a 10b5-1 plan adopted Nov 5, 2024
- Jan 26, 2026 Planned sale Rebecca Taub (Director) gave notice of a planned sale of 647 shares worth about $311KForm 144, approximate sale date Jan 26, 2026
- Jan 26, 2026 Planned sale William Sibold (Officer and Director) gave notice of a planned sale of 1,577 shares worth about $758KForm 144, approximate sale date Jan 26, 2026
- Jan 26, 2026 Planned sale Carole Huntsman (Officer) gave notice of a planned sale of 340 shares worth about $163KForm 144, approximate sale date Jan 26, 2026
- Jan 20, 2026 Planned sale SHANNON KELLEY (Officer) gave notice of a planned sale of 429 shares worth about $215KForm 144, approximate sale date Jan 20, 2026, under a 10b5-1 plan adopted Nov 7, 2024
- Jan 20, 2026 Planned sale Rebecca Taub (Director) gave notice of a planned sale of 2,238 shares worth about $1.1MForm 144, approximate sale date Jan 20, 2026
- Jan 20, 2026 Planned sale Shannon Kelley (Officer) gave notice of a planned sale of 263 shares worth about $132KForm 144, approximate sale date Jan 20, 2026
- Jan 9, 2026 Planned sale REBECCA A TAUB (Director) gave notice of a planned sale of 18,650 shares worth about $10.4MForm 144, approximate sale date Jan 9, 2026, under a 10b5-1 plan adopted Sep 10, 2025
- Dec 11, 2025 Officer CAO change(the “Company”) appointed Rita Thakkar as Senior Vice President and Chief Accounting Officer of the Company, effective January 12, 2026.
- Dec 10, 2025 Planned sale REBECCA A TAUB (Director) gave notice of a planned sale of 18,650 shares worth about $10.3MForm 144, approximate sale date Dec 10, 2025, under a 10b5-1 plan adopted Sep 10, 2025
- Dec 10, 2025 Planned sale PAUL FRIEDMAN (Director) gave notice of a planned sale of 49,600 shares worth about $27.5MForm 144, approximate sale date Dec 10, 2025, under a 10b5-1 plan adopted Sep 10, 2025
- Dec 4, 2025 Planned sale William John Sibold (Officer and Director) gave notice of a planned sale of 2,400 shares worth about $1.4MForm 144, approximate sale date Dec 4, 2025
- Dec 2, 2025 Planned sale MARDI C DIER (Officer) gave notice of a planned sale of 4,173 shares worth about $2.4MForm 144, approximate sale date Dec 2, 2025, under a 10b5-1 plan adopted Sep 2, 2025
- Nov 21, 2025 Planned sale Carole Huntsman (Officer) gave notice of a planned sale of 1,958 shares worth about $1.1MForm 144, approximate sale date Nov 21, 2025, under a 10b5-1 plan adopted Nov 5, 2024
- Nov 4, 2025 Planned sale Richard Levy, M.D. (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 16,682 shares, runs to Dec 31, 2026
- Nov 4, 2025 Planned sale Mardi Dier (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,337 shares, runs to Dec 31, 2026
- Nov 4, 2025 Planned sale Paul Friedman, M.D. (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 49,600 shares, runs to Feb 28, 2027
- Nov 4, 2025 Planned sale Rebecca Taub, M.D. (Senior Scientific and Medical Advisor and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 37,300 shares, runs to Feb 28, 2027
- Nov 4, 2025 8-K Quarterly results8-K item 2.02
- Nov 4, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Aug 5, 2025 8-K Quarterly results8-K item 2.02
- Aug 5, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 30, 2025 8-K Regulation FD disclosure8-K item 7.01
- Jul 22, 2025 8-K Material agreement signed, Material agreement ended, New debt or obligation, Regulation FD disclosure8-K items 1.01, 1.02, 2.03, 7.01
- Jun 20, 2025 8-K Shareholder vote results8-K item 5.07
- May 1, 2025 Planned sale Paul Friedman, M.D., (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 206,256 shares, runs to Jul 22, 2026
- May 1, 2025 Planned sale Rebecca Taub, M.D., (Senior Scientific and Medical Advisor and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 76,564 shares, runs to Jul 22, 2026
- May 1, 2025 8-K Quarterly results8-K item 2.02
- May 1, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 17, 2025 8-K Director or officer change8-K item 5.02
- Mar 11, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Feb 26, 2025 Planned sale Bill Sibold (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 7,616 shares
- Feb 26, 2025 Planned sale Carole Huntsman (Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 4,701 shares
- Feb 26, 2025 Planned sale Mardi Dier (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 2,218 shares
- Feb 26, 2025 Planned sale Shannon Kelley (General Counsel) adopted a 10b5-1 trading planreported in the 10-K, up to 2,409 shares
- Feb 26, 2025 8-K Quarterly results8-K item 2.02
- Feb 26, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Jan 13, 2025 8-K Quarterly results8-K item 2.02
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 6, 2026 | 144 | Notice of planned insider sale |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 6, 2026 | SCHEDULE 13D/A | 5%+ owner (active), amended |
| Nov 3, 2026 | 10-Q | Quarterly report |
| Nov 3, 2026 | 8-K | Quarterly results |
| Sep 28, 2026 | 144 | Notice of planned insider sale |
| Sep 11, 2026 | 144 | Notice of planned insider sale |
| Sep 11, 2026 | 4 | Insider trade |
| Sep 9, 2026 | 144 | Notice of planned insider sale |
| Aug 20, 2026 | 4 | Insider trade |
| Aug 20, 2026 | 144 | Notice of planned insider sale |
| Aug 18, 2026 | 4 | Insider trade |
| Aug 18, 2026 | 3 | New insider |
| Aug 12, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Jul 30, 2026 | 10-Q | Quarterly report |
| Jul 30, 2026 | 8-K | Quarterly results |
| Jul 29, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 20, 2026 | 4 | Insider trade |
| Jul 20, 2026 | 144 | Notice of planned insider sale |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 17, 2026 | S-8 | Shares registered for employee plans |
| Jun 17, 2026 | 8-K | Director or officer change, Shareholder vote results |
| Jun 1, 2026 | 144 | Notice of planned insider sale |
| Jun 1, 2026 | 4 | Insider trade |
| May 22, 2026 | 144 | Notice of planned insider sale |
| May 22, 2026 | 4 | Insider trade |
| May 18, 2026 | 4 | Insider trade |
| May 18, 2026 | 144 | Notice of planned insider sale |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 6, 2026 | 10-Q | Quarterly report |
| May 6, 2026 | 8-K | Quarterly results |
| Apr 28, 2026 | 8-K | Director or officer change |
| Apr 28, 2026 | DEF 14A | Proxy statement |
| Apr 28, 2026 | ARS | Annual report to shareholders |
| Apr 28, 2026 | DEFA14A | Extra proxy material |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 6, 2026 | 144 | Notice of planned insider sale |
| Mar 6, 2026 | 4 | Insider trade |
| Mar 6, 2026 | 144 | Notice of planned insider sale |
| Mar 6, 2026 | 4 | Insider trade |
| Mar 6, 2026 | 144 | Notice of planned insider sale |
| Mar 6, 2026 | 4 | Insider trade |
| Mar 6, 2026 | 144 | Notice of planned insider sale |
| Mar 6, 2026 | 4 | Insider trade |
| Mar 6, 2026 | 144 | Notice of planned insider sale |
| Mar 6, 2026 | 4 | Insider trade |
| Mar 6, 2026 | 144 | Notice of planned insider sale |
| Mar 6, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 144 | Notice of planned insider sale |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 19, 2026 | 10-K | Annual report |
| Feb 19, 2026 | 8-K | Quarterly results |
| Feb 17, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 17, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jan 30, 2026 | 8-K | Material agreement signed |
| Jan 26, 2026 | 144 | Notice of planned insider sale |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 26, 2026 | 144 | Notice of planned insider sale |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 26, 2026 | 144 | Notice of planned insider sale |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 26, 2026 | 144 | Notice of planned insider sale |
| Jan 20, 2026 | 144 | Notice of planned insider sale |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 144 | Notice of planned insider sale |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 144 | Notice of planned insider sale |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 3 | New insider |
| Jan 13, 2026 | 4 | Insider trade |
| Jan 13, 2026 | 4 | Insider trade |
| Jan 13, 2026 | 4 | Insider trade |
| Jan 13, 2026 | 4 | Insider trade |
| Jan 9, 2026 | 144 | Notice of planned insider sale |
| Dec 12, 2025 | 4 | Insider trade |
| Dec 12, 2025 | 4 | Insider trade |
| Dec 12, 2025 | SCHEDULE 13D/A | 5%+ owner (active), amended |
| Dec 12, 2025 | SCHEDULE 13D/A | 5%+ owner (active), amended |
| Dec 11, 2025 | 8-K | Director or officer change |
| Dec 10, 2025 | 144 | Notice of planned insider sale |
| Dec 10, 2025 | 144 | Notice of planned insider sale |
| Dec 4, 2025 | 4 | Insider trade |
| Dec 4, 2025 | 144 | Notice of planned insider sale |
| Dec 3, 2025 | 4 | Insider trade |
| Dec 2, 2025 | 144 | Notice of planned insider sale |
| Nov 21, 2025 | 4 | Insider trade |
| Nov 21, 2025 | 144 | Notice of planned insider sale |
| Nov 14, 2025 | 4 | Insider trade |
| Nov 14, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 13, 2025 | 144 | Notice of planned insider sale |
| Nov 7, 2025 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MDGL/export.csv") into a cell.